Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial
ContributorsBecker, Clemens; Lord, Stephen R; Studenski, Stephanie A; Warden, Stuart J; Fielding, Roger A; Recknor, Christopher P; Hochberg, Marc C; Ferrari, Serge Livio; Blain, Hubert; Binder, Ellen F; Rolland, Yves; Poiraudeau, Serge; Benson, Charles T; Myers, Stephen L; Hu, Leijun; Ahmad, Qasim I; Pacuch, Kelli R; Gomez, Elisa V; Benichou, Olivier
Published inThe Lancet. Diabetes & endocrinology, vol. 3, no. 12, p. 948-957
Publication date2015
Affiliation entities
Research groups
Citation (ISO format)
BECKER, Clemens et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. In: The Lancet. Diabetes & endocrinology, 2015, vol. 3, n° 12, p. 948–957. doi: 10.1016/S2213-8587(15)00298-3
Main files (1)
Article (Published version)
Identifiers
- PID : unige:78976
- DOI : 10.1016/S2213-8587(15)00298-3
Additional URL for this publicationhttp://linkinghub.elsevier.com/retrieve/pii/S2213858715002983
Journal ISSN2213-8587
